Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 54 | -161 | -126 | -717 | -579 |
| Depreciation Amortization | 7 | 3 | 1 | 6 | 4 |
| Accounts receivable | -932 | -299 | 74 | -16 | -737 |
| Accounts payable and accrued liabilities | 317 | -41 | -192 | 191 | 1,150 |
| Other Working Capital | -29 | -362 | -164 | -212 | -295 |
| Other Operating Activity | 622 | 341 | 119 | -169 | -407 |
| Operating Cash Flow | $39 | $-520 | $-288 | $-917 | $-864 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59 | -18 | N/A | -8 | -7 |
| Other Investing Activity | 0 | 9 | 0 | 0 | 0 |
| Investing Cash Flow | $-59 | $-9 | $0 | $-8 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 450 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 1 | 1 |
| Other Financing Activity | 450 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $450 | $450 | $0 | $1 | $1 |
| Beginning Cash Position | 1,039 | 1,039 | 1,039 | 1,964 | 1,964 |
| End Cash Position | 1,469 | 961 | 751 | 1,039 | 1,094 |
| Net Cash Flow | $430 | $-78 | $-288 | $-925 | $-870 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39 | -520 | -288 | -917 | -864 |
| Capital Expenditure | -59 | -18 | 0 | -8 | -7 |
| Free Cash Flow | -20 | -537 | -288 | -926 | -871 |